Alvotech (NASDAQ:ALVOW – Get Free Report) was the target of a large decrease in short interest in March. As of March 13th, there was short interest totaling 932 shares, a decrease of 35.5% from the February 26th total of 1,444 shares. Based on an average daily volume of 1,248 shares, the days-to-cover ratio is presently 0.7 days.
Alvotech Price Performance
Shares of NASDAQ:ALVOW opened at $0.31 on Monday. The firm has a fifty day moving average price of $0.37 and a two-hundred day moving average price of $0.79. Alvotech has a one year low of $0.15 and a one year high of $3.00.
About Alvotech
Alvotech is a biopharmaceutical company specializing in the development and manufacturing of biosimilar medicines. Headquartered in Reykjavík, Iceland, the company focuses on creating high-quality, cost-effective alternatives to branded biologic therapies. Since its founding in 2013, Alvotech has built an integrated platform that spans research and development, clinical trials, regulatory submissions and commercial manufacturing.
Alvotech’s pipeline includes multiple biosimilar candidates addressing key therapeutic areas such as immunology, oncology and ophthalmology.
Featured Articles
Receive News & Ratings for Alvotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alvotech and related companies with MarketBeat.com's FREE daily email newsletter.
